Sandra Benito-Blasco
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
Journal: Oncogene
Published: August 06, 2025
Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer.
Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer.
Journal: The Journal of clinical investigation
Published: March 07, 2025
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak.
Journal: Cancer cell
Published: April 17, 2024
Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.
Journal: Cell death discovery
Published: November 14, 2023
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.
Journal: Molecular therapy. Nucleic acids
Published: May 31, 2022
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
Journal: Nature communications
Published: April 18, 2022
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 09, 2019
Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.
Journal: Biochemical pharmacology
Published: May 30, 2018
New inhibitors of angiogenesis with antitumor activity in vivo.
Journal: Journal of medicinal chemistry
Published: April 24, 2015
Last Updated: 09/26/2026